Levonorgestrel contraceptive implants in female patients 14 to 21 years old

Mayo Clinic Proceedings

Volumn 73, Issue 1, 1998, Pages 10-16

  Suman, Vera J ^a   Van Winter, Jo T ^b,c   Evans, Mary P ^b   Summons, Patricia S ^b   Jacobsen, Steven J ^c   Manolis, Amy L ^b  

^a Section of Biostatistics   (United States)

^b Department of Obstetrics and Gynecology ^*  (United States)

^c MAYO CLINIC ROCHESTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LEVONORGESTREL;

ACNE; ADOLESCENT; ADULT; AMENORRHEA; ARTICLE; BLEEDING; DEPRESSION; DRUG IMPLANT; DRUG USE; FEMALE; FOLLOW UP; HEADACHE; HORMONAL CONTRACEPTION; HUMAN; MAJOR CLINICAL STUDY; RETROSPECTIVE STUDY; STATISTICAL ANALYSIS; WEIGHT GAIN;

EID: 0031883298     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0025-6196(11)63613-6     Document Type: Article

References (24)

1. Van Winter JT, Simmons PS. A proposal for obstetric and pédiatrie management of adolescent pregnancy. Mayo Clin Proc 1990;65:1061 -1066
2. Alan Guttmacher Institute. Teenage Sexual Reproductive Behavior in the United States, Facts in Brief. New York: Alan Guttmacher Institute; 1993
3. Hammerslough CR. Characteristics of women who stop using contraceptives. Fam Plann Perspect 1984;16:14-18
4. Harlap S, Kost K, Forrest JD. Preventing Pregnancy, Protecting Health: A New Look at Birth Control Choices in the United States. New York: Alan Guttmacher Institute; 1991. pp 36-37
5. Hillard PJ. Oral contraception noncompliance: the extent of the problem. Adv Contracept 1992;8(Suppl 1): 13-20
6. Jones EF, Forrest JD. Contraceptive failure rates based on the 1988 NSFG. Fam Plann Perspect 1992;24:12-19
7. American College of Obstetricians and Gynecologists. ACOG technical bulletin: hormonal contraception; number 198-October 1994. Int J Gynecol Obstet 1995;48:115-126
8. Berenson AB, Wiemann CB. Patient satisfaction and side effects with levonorgestrel implant (Norplant) use in adolescents 18 years of age or younger. Pediatrics 1993;92:257260
9. Cunningham FG, MacDonald PC, Leveno KJ, Gant NF, Gilstrap LC III. Williams Obstetrics. 19th ed. Norwalk (CT): Appleton and Lange; 1993. p 1323
10. Cromer B A, Smith RD, Blair JM, Dwyer J, Brown RT. A prospective study of adolescents who choose among levonorgestrel implant (Norplant), medroxyprogesterone acetate (Depo-Provera), or the combined oral contraceptive pill as contraception. Pediatrics 1994;94:687-694
11. Crosby UD, Schwarz BE, Gluck KL, Heartwell SF. A preliminary report of Norplant implant insertions in a large urban family planning program. Contraception 1993;48:359-366
12. Cullins VE, Remsburg RE, Blumenthal PD, Huggins GR. Comparison of adolescent and adult experiences with Norplant levonorgestrel contraceptive implants. Obstet Gynecol 1994; 83:1026-1032
13. Grimes DA. Contraception for adolescents: folic acid to prevent neural tube defects. Contracept Rep 1993 Jul;4:415
14. Polaneczky M, Slap G, Forke C, Rappaport A, Sondheimer S. The use of levonorgestrel implants (Norplant) for contraception in adolescent mothers. N Engl J Med 1994;331:1201-1206
15. van Amerongen D. Removal rates of subdermal levonorgestrel implants. JReprodMed 1994;39:873-876
16. Rosenthal SL, Biro FM, Kollar LM, Hillard PJ, Rauh JL. Experience with side effects and health risks associated with Norplant implant use in adolescents. Contraception 1995; 52:283-285
17. Levine AS, Holmes MM, Haseldon C, Butler W, Tsai C. Subdermal contraceptive implant (Norplant) continuation rates among adolescents and adults in a family planning clinic. J Pediatr Adolesc Gynecol 1996;9:67-70
18. Emans SJ, Grace E, Woods ER, Smith DE, Klein K, Merola J. Adolescents' compliance with the use of oral contraceptives. JAMA 1987;257:3377-3381
19. Balassone ML. Risk of contraceptive discontinuation among adolescents. J Adolesc Health 1989; 10:527-533
20. Freeman EW, Rickels K, Mudd EB, Huggins GR. Neverpregnant adolescents and family planning programs: contraception, continuation, and pregnancy risk. Am J Public Health 1982;72:815-822
21. Kirk EP, Field CS. Difficult Norplant removal facilitated by fluoroscopy [letter]. Am J Obstet Gynecol 1993;169: 748
22. Cullins VE, Blumenthal PD, Remsburg RE, Huggins GR. Preliminary experience with Norplant in an inner city population. Contraception 1993;47:193-203
23. Post SG. Implantable hormonal contraceptives: emerging controversy. Obstet Gynecol 1994;84:1055-1057
24. Kaunitz AM, Mishell DR Jr. Progestin-only contraceptives: current perspectives and future directions. Dialog Contracept 1994;4(No. 2): 1-5